What Dagravit Total 30 Treats: Main Uses and Benefits

Dagravit Total 30 generally functions as a comprehensive nutritional support system, focusing on preventing and correcting non-specific discomforts associated with suboptimal micronutrient status rather than treating specific diseases. Essential vitamins and minerals may be vital for energy production, immune function, and overall systemic health, making supplementation relevant when diet alone is insufficient.

It is commonly used to help with symptoms of general tiredness and easy fatigability when these manifestations may be linked to an inadequate diet, particularly gaps in B-vitamins and Iron. The supplement is also applied in addressing contexts marked by restrictive eating patterns or periods of increased physiological demand that may create mild nutritional insufficiency.

Dagravit Total 30 plays a role in managing systemic resilience, specifically supporting the proper function of the immune system and contributing to the supportive foundation for general health maintenance in patient groups such as older adults and individuals with high activity levels.

Quick Fact: Relief for Nutritional Gaps

This preparation assists with maintaining functional stability by addressing marginal nutritional status and contributes to easing the overall symptom load of non-specific malaise.

Eligibility: Official Regulatory Information

The eligibility for using Dagravit Total 30 is strictly defined by official regulatory labeling, which establishes specific age groups for use, absolute prohibitions, and conditions that require mandatory expert consultation.

Classification	Eligibility Status
Approved Age Groups	Adults (18 years and older). Children from 4 years up to 17 years (at age-specific regulatory limits).
Absolute Contraindication	Individuals with known hypersensitivity to any of the vitamins, minerals, or excipients in the formulation.
Prohibited Use	Children under the age of 4 (or up to age 17, depending on dosage) due to regulatory limits on Vitamin B6 content.
Conditional Use	Individuals who are pregnant, lactating, suffering from a chronic illness (e.g., diabetes), or taking medication. Expert consultation is mandatory before use in these populations.

The product is categorized for generally healthy adults and requires mandatory professional review for vulnerable or medically complex populations. The use-not-established status applies to those who bypass the mandatory consultation for conditional-use categories.

Interactions with other medicines and products

Dagravit Total 30 is a multivitamin and mineral preparation. The official interaction profile is structured around the binding properties of the polyvalent cations (Iron, Calcium) and the metabolic effects of Folic Acid, as described in government drug labels and monographs.

Timing-Based Interaction Constraints

Co-administration with the supplement requires mandatory timing separation for certain oral medications. The Iron and Calcium components may reduce the absorption and bioavailability of drugs such as Quinolone antibiotics (e.g., Ciprofloxacin), Tetracycline antibiotics (e.g., Doxycycline), and Thyroid medications (e.g., Levothyroxine) through chelation. Regulatory documents stipulate that these medicines must be administered at least two hours before or two hours after the multivitamin/mineral preparation to minimize reduced drug exposure.

Exposure-Modifying Substances

Official documents note that the Folic Acid component may alter the clearance and reduce the effectiveness of the anti-seizure drug Phenytoin. Additionally, the Iron component may reduce the absorption of Levodopa and certain Bisphosphonates, a significant interaction classified as Major in some regulatory systems.

Food and Supplement Restrictions

Concurrent use with Antacids, Milk, Dairy Products, Tea, or Coffee may reduce the absorption of the Iron component. Furthermore, co-administration with other vitamin/mineral supplements containing high levels of Iron or fat-soluble vitamins (A, D, E, K) must be restricted due to the official risk of additive micronutrient exposure.

How Dagravit Total 30 Works: Mechanism of Action

Cellular Energy Metabolism

This mechanism centers on the B-group vitamins ( B1, B2, B3, B5, B6) acting as essential coenzymes to participate in key metabolic pathways, including the Krebs cycle and oxidative phosphorylation. By saturating the enzyme systems responsible for converting macronutrients into ATP, the process contributes to ATP generation capacity and cellular maintenance across all tissues.

Integrated Antioxidant and Redox Cascade

The formulation acts by providing direct antioxidants (Vitamins C, E) and cofactors ( Zinc, Selenium) necessary for major endogenous enzymes like Superoxide Dismutase. This combined action functions to quench Reactive Oxygen Species and influence the cellular redox state, influencing the processes related to membrane and DNA structural integrity.

Structural and Hematopoietic Homeostasis

The mechanism includes the hormone-like regulation of Calcium absorption by Vitamin D to facilitate the mineralization of skeletal tissue. Separately, it facilitates blood cell production through the co-dependence of Iron, Folate, and Vitamin B12 in DNA synthesis and oxygen transport, participating in the pathways for tissue synthesis and systemic oxygen transport.

The use of Dagravit Total 30 is governed by explicit instructions detailing the required route, daily quantity, frequency, and administration timing, consistent with global regulatory practices for multivitamin/mineral (MVM) supplements.

Administration Scope

Instruction	Detail
Route of administration	Oral use (ingestion by mouth).
Dosing schedule	Adults (Ages 18+): 1 to 3 dragees per day. Adolescents (Ages 12+): 1 to 2 dragees per day.
Timing in relation to meals	The dragee should preferably be taken during meals.
Preparation requirements	To be swallowed whole with water. No dilution or reconstitution required.
Age-group administration rules	Children (Ages 4-12 years): 1 dragee per day. The product is not suitable for children up to and including 3 years.
Special procedural conditions	The recommended daily dosage must not be exceeded. This restriction is a standard administration principle designed to prevent intake above established Tolerable Upper Intake Levels for certain components.

---

Instruction Classifications (high-level)

Classification	Detail
Administration method type	Oral (tablet/dragee)
Frequency pattern	Daily (intended for continuous consumption).
Regulatory basis	National Health Agencies/Official Labeling.
Use-context constraints	Must be taken with a meal and must respect the age-specific quantity limits.

---

Resulting procedural structure

Official step sequence:

• Take the specified number of dragees once daily.
• Consume the dragee during a meal.
• Swallow the dragee whole with water.

Connection to the overall use protocol (2–4 sentences):

The official instructions establish a standardized, non-exceedable daily dose taken through the oral route. This structured approach defines the required frequency and the crucial timing constraint of administration with meals, ensuring the standardized method of use according to regulatory guidelines.

Research Evidence / Overview of Studies for Dagravit Total 30

This overview summarizes the scientific studies conducted on broad-spectrum multivitamin/mineral preparations, which align with the composition of Dagravit Total 30. This summary focuses only on the structure and findings of scientific research and must not be used as medical advice, personal guidance, or a recommendation for treatment.

---

Evidence on Nutritional Status and Micronutrient Repletion

Research examined the role of these preparations in contributing to the daily intake of essential nutrients. Studies monitored blood and serum biomarkers for various vitamins and minerals to see how concentrations changed in individuals who reported using supplements. Findings described patterns where those who used multivitamin/mineral preparations were generally associated with a higher prevalence of achieving nutrient adequacy, meaning these individuals were observed to meet the established Recommended Daily Amounts (RDAs) for many micronutrients. A key limitation is the 'healthy user bias' often observed in this type of research, which may complicate the interpretation of findings.

Research on Cognitive Function and Age-Related Changes

The multivitamin/mineral preparation was evaluated in research exploring specific populations, mainly generally healthy older adults aged 65 and over. This area benefits from large-scale, long-term Randomized Controlled Trials (RCTs). These studies monitored outcomes using various cognitive assessment scores, focusing on functions like episodic memory and the rate of cognitive aging. The reported findings described patterns where the rate of change in these assessment scores sometimes was associated with the intervention compared to the control groups. Data for certain groups, such as younger adult populations, remain insufficient.

Studies Investigating General Tiredness and Wellbeing

Research examined multivitamin/mineral preparations in trials assessing short-term or episodic symptom patterns related to general tiredness and perceived energy levels. The findings for this application were mixed, and evidence quality varies across studies. Studies monitored changes in subjective fatigue scale scores. The evidence highlights that the follow-up durations were limited in many interventional trials, providing limited insight into potential sustained changes.

Research on Systemic Support and Immune Function

Multivitamin/mineral use was evaluated in research exploring systemic support and immune function, particularly in older adults. Findings regarding data show patterns related to the frequency of infections were mixed and often inconsistent across different systematic analyses. Certainty remains low for evidence exploring the prevention of infections in generally healthy, non-deficient older adults, and long-term effects are not fully established regarding measures of systemic function.

Key Studies & References

1. Effect of multivitamin/mineral supplementation on fatigue and mood: a systematic review and meta-analysis of randomized controlled trials

Common questions about Dagravit Total 30 (FAQ)

Q: What should I do if I miss a day of taking the supplement?

If a dose is forgotten, official dosing information indicates that it may be taken as soon as it is remembered. However, if it is close to the time for the next scheduled dose, the missed dose should be skipped. The labeling advises against taking a double dose or two doses at the same time to compensate for a missed dose.

---

Q: What is the best time of day to take Dagravit Total 30 (morning, afternoon, or evening)?

Official administration instructions specify that the supplement should be taken during a meal once a day. Regulatory documents do not specify whether the morning, afternoon, or evening meal is preferable. The core administration constraint is taking it with a meal, which is consistent with general guidelines for this type of supplement.

---

Q: Can I split the dragee or chew it instead of swallowing it whole?

The official product information specifies that the dragee (coated tablet) must be swallowed whole with water. Breaking the coating may alter the release characteristics of the components, which is not consistent with the intended method of use described in the regulatory labeling.

---

Q: Is Dagravit Total 30 safe to take while pregnant or breastfeeding?

Regulatory eligibility documents classify pregnant and lactating individuals as a Conditional Use population. This means the preparation is not for general use in these groups without medical clearance. Consultation is a mandatory step before use for pregnant or lactating individuals.

---

Q: What is the best way to dispose of expired or unused Dagravit Total 30?

Standard guidelines for disposing of unused supplements often suggest mixing the product (do not crush the tablets) with an unappealing substance, such as used coffee grounds or cat litter. The mixture can be placed in a sealed container or bag for disposal with household trash. This practice helps prevent accidental ingestion.

---

Q: Where is the Dagravit Total 30 product manufactured or sourced from?

Regulatory labeling requires the name and place of business of the manufacturer, packer, or distributor to be included. The provided product content identifies the distributor as the Dutch company Vemedia B.V., but the provided product information does not specify the exact manufacturing location.

---

Q: Are there any lifestyle factors (e.g., alcohol, smoking) that interact with the supplement?

Official interaction profiles primarily list known drug, food, and supplement interactions. While alcohol is not typically listed as a direct contraindication, chronic heavy use can interfere with the body's absorption of several B-vitamins. Any concerns regarding lifestyle factors should be discussed with a healthcare provider.

---

Q: How should Dagravit Total 30 be stored for maximum freshness?

Official documents describe the necessary storage conditions to maintain product stability and effectiveness. These conditions include storing it at room temperature (15-25 C), keeping it in a dry and dark place to protect it from moisture and light, and ensuring the container is kept tightly sealed.

Official Storage and Handling Requirements

Regulatory documents define specific conditions for storing Dagravit Total 30 to maintain its stability and effectiveness. The product must be stored within the following constraints, as defined by official labeling.

Storage Requirement	Condition
Temperature	Room temperature (15-25 C)
Environmental Protection	Store dry and dark (protect from moisture and light)
Container Integrity	Keep container sealed (Afgesloten)
Child Safety	Keep out of reach of young children

Disposal

Official labeling does not provide product-specific instructions for the disposal of unused or expired Dagravit Total 30. Standard health guidelines recommend following local regulations for the safe disposal of medicinal products.